Male breast cancer: A survey at the Helsinki University Central Hospital during 1981-2006

Acta Oncologica

Volumn 49, Issue 3, 2010, Pages 322-327

  Liukkonen, Sanna ^a   Saarto, Tiina ^a   Mäenpää, Hanna ^a   Sjöström Mattson, Johanna ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; LETROZOLE; MEDROXYPROGESTERONE ACETATE; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CANCER SURVIVAL; DISTANT METASTASIS; FAMILY HISTORY; FOLLOW UP; GENE OVEREXPRESSION; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MASTECTOMY; MEDICAL RECORD REVIEW; OBESITY; OVERALL SURVIVAL; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SENTINEL LYMPH NODE; SEX DIFFERENCE; SYMPTOM; UNIVERSITY HOSPITAL; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; AXILLA; BONE NEOPLASMS; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FINLAND; HUMANS; LYMPH NODE EXCISION; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OBESITY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951276237     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003591723     Document Type: Article

References (25)

1. Johnson KC, Pan S, Mao Y, Canadian Cancer Registries Epidemiology Research Group. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 2002; 11:253-263 (Pubitemid 34753885)
2. Karlsson CT, Malmer B, Wiklund F, Gronberg H. Breast cancer as a second primary in patients with prostate cancer- estrogen treatment or association with family history of cancer? J Urol 2006;176:538-543 (Pubitemid 43927896)
3. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 1998;93:231-233 (Pubitemid 29063974)
4. Guenel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, et al. Alcohol drinking may increase risk of breast cancer in men: A European population-based case-control study. Cancer Causes Control 2004;15:571-580 (Pubitemid 39070075)
5. Walshe JM, Berman AW, Vatas U, Steinberg SM, Anderson WF, Lippman ME, et al. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat 2007;103:177-183 (Pubitemid 46789139)
6. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999;85:629-639 (Pubitemid 29075284)
7. Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 2010;73:246-254
8. Sankila R; Chief Medical Officer of the Finnish Cancer Registry at the Institute for Statistical and Epidemiological Cancer Research. Personal communication 2009.
9. Fonseca RR, Tomas AR, Andre S, Soares J. Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer. Am J Surg Pathol 2006;30:1292-1298 (Pubitemid 44454709)
10. Koninki K, Tanner M, Auvinen A, Isola J. HER-2 positive breast cancer: Decreasing proportion but stable incidence in Finnish population from 1982 to 2005. Breast Cancer Res 2009;11:R37.
11. Chandrasekharan S, Fasanya C, Macneill FA. Invasive lobular carcinoma of the male breast: Do we need to think of Klinefelter's syndrome? Breast 2001;10:176-178 (Pubitemid 32396379)
12. Spencer JT, Shutter J. Synchronous bilateral invasive lobular breast cancer presenting as carcinomatosis in a male. Am J Surg Pathol 2009;33:470-474
13. Brinton LA, Richesson DA, Gierach GL, Lacey JV, Jr, Park Y, Hollenbeck AR, et al. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 2008; 100:1477-1481
14. Thellenberg C, Malmer B, Tavelin B, Gronberg H. Second primary cancers in men with prostate cancer: An increased risk of male breast cancer. J Urol 2003;169: 1345-1348 (Pubitemid 36323781)
15. Lee UJ, Jones JS. Incidence of prostate cancer in male breast cancer patients: A risk factor for prostate cancer screening. Prostate Cancer Prostatic Dis 2009;12:52-56
16. Satram-Hoang S, Ziogas A, Anton-Culver H. Risk of second primary cancer in men with breast cancer. Breast Cancer Res 2007;9:R10. (Pubitemid 350215151)
17. Appelqvist P, Salmo M. Prognosis in carcinoma of the male breast. Acta Chir Scand 1982;148:499-502. (Pubitemid 12018663)
18. Giordano SH, Hortobagyi GN. Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 2006;24:e42-3.
19. Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 2002;25:235-237 (Pubitemid 34602542)
20. Italiano A, Largillier R, Marcy PY, Foa C, Ferrero JM, Hartmann MT, et al. Complete remission obtained with letrozole in a man with metastatic breast cancer. Rev Med Interne 2004;25:323-324 (Pubitemid 38438416)
21. Zabolotny BP, Zalai CV, Meterissian SH. Successful use of letrozole in male breast cancer: A case report and review of hormonal therapy for male breast cancer. J Surg Oncol 2005;90:26-30.
22. Arriola E, Hui E, Dowsett M, Smith IE. Aromatase inhibitors and male breast cancer. Clin Transl Oncol 2007;9:192-194
23. Carmona-Bayonas A. Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer. Breast 2007;16:323-325 (Pubitemid 46796856)
24. Doyen J, Italiano A, Largillier R, Ferrero JM, Fontana X, Thyss A. Aromatase inhibition in male breast cancer patients: Biological and clinical implications. Ann Oncol 2009.
25. Marchal F, Salou M, Marchal C, Lesur A, Desandes E. Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol 2009;16:972-8.